Immunometabolism of regulatory T cells

Nature Immunology

Volumn 17, Issue 6, 2016, Pages 618-625

  Newton, Ryan ^a   Priyadharshini, Bhavana ^a   Turka, Laurence A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 2; LEPTIN; MEVALONIC ACID; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PURINERGIC P2X7 RECEPTOR; REACTIVE OXYGEN METABOLITE; SIRTUIN; SIRTUIN 1; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NFAT;

ADIPOCYTE; CATABOLISM; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL METABOLISM; CITRIC ACID CYCLE; CYTOKINE PRODUCTION; ENERGY METABOLISM; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMETABOLISM; IMMUNOMODULATION; LIVER CELL; LYMPHOCYTE; MACROPHAGE; METABOLIC REGULATION; MITOCHONDRIAL BIOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; ANIMAL; HOMEOSTASIS; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLIC SYNDROME X; METABOLISM; MICROFLORA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

ADIPOCYTES; ANIMALS; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; IMMUNITY; MACROPHAGES; METABOLIC SYNDROME X; MICROBIOTA; OBESITY; PERIPHERAL TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 84970028297     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3466     Document Type: Review

References (86)

1. Yadav M, Stephan S, & Bluestone J.A. Peripherally induced tregs-role in immune homeostasis and autoimmunity. Front. Immunol. 4, 232 (2013).
2. Abbas A.K, et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14, 307-308 (2013).
3. Curotto de Lafaille M.A, & Lafaille J.J. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity. 30, 626-635 (2009).
4. Ohkura N, et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell develop-ment. Immunity. 37, 785-799 (2012).
5. Maloy K.J, & Powrie F. Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat. Immunol. 6, 1071-1072 (2005).
6. Fontenot J.D, Rasmussen J.P, Gavin M.A, & Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151 (2005).
7. DCruz L.M, & Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6, 1152- 1159 (2005).
8. Pollizzi K.N, & Powell J.D. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 14, 435-446 (2014).
9. Wang R, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 35, 871-882 (2011).
10. Pearce E.L, Poffenberger M.C, Chang C.-H, & Jones R.G. Fueling immunity: insights into metabolism and lymphocyte function. Science. 342, 1242454 (2013).
11. van der Windt G.J, et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity. 36, 68-78 (2012).
12. Pearce E.L, et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 460, 103-107 (2009).
13. Michalek R.D, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299-3303 (2011).
14. Berod L, et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20, 1327-1333 (2014).
15. Chang C.-H, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 153, 1239-1251 (2013).
16. Gerriets V.A, et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125, 194-207 (2015).
17. Shi L.Z, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic check-point for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367-1376 (2011).
18. Zeng H, et al. mTORC1 couples immune signals and metabolic programming to estab-lish Treg-cell function. Nature. 499, 485-490 (2013).
19. Ho P.-C, et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-Tumor t cell responses. Cell. 162, 1217-1228 (2015).
20. Lee C.-F, et al. Preventing allograft rejection by targeting immune metabolism. Cell Reports. 13, 760-770 (2015).
21. Procaccini C, et al. The proteomic landscape of human ex vivo regulatory and conven-Tional T cells reveals specific metabolic requirements. Immunity. 44, 406-421 (2016).
22. Klysz D, et al. Glutamine-dependent a-ketoglutarate production regulates the bal-Ance between T helper 1 cell and regulatory T cell generation. Sci. Signal. 8, ra97 (2015).
23. Sinclair L.V, et al. Control of amino-Acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14, 500-508 (2013).
24. Nakaya M, et al. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity. 40, 692- 705 (2014).
25. Mezrich J.D, et al. An interaction between kynurenine and the aryl hydrocarbon recep-Tor can generate regulatory T cells. J. Immunol. 185, 3190-3198 (2010).
26. Opitz C.A, et al. An endogenous tumour-promoting ligand of the human aryl hydrocar-bon receptor. Nature. 478, 197-203 (2011).
27. Buck M.D, OSullivan D, & Pearce E.L. T cell metabolism drives immunity. J. Exp. Med. 212, 1345-1360 (2015).
28. Priyadharshini B, & Turka L.A. T-cell energy metabolism as a controller of cell fate in transplantation. Curr. Opin. Organ Transplant. 20, 21-28 (2015).
29. Cui G, et al. IL-7-induced glycerol transport and TAG synthesis promotes memory CD8+ T cell longevity. Cell. 161, 750-761 (2015).
30. OSullivan D, et al. Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity. 41, 75-88 (2014).
31. Cipolletta D, et al. PPAR-g is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 486, 549-553 (2012).
32. Zeng H, & Chi H. Metabolic control of regulatory T cell development and function. Trends Immunol. 36, 3-12 (2015).
33. Burzyn D, Benoist C, & Mathis D. Regulatory T cells in nonlymphoid tissues. Nat. Immunol. 14, 1007-1013 (2013).
34. Procaccini C, et al. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity. 33, 929-941 (2010).
35. Procaccini C, Galgani M, De Rosa V, & Matarese G. Intracellular metabolic pathways control immune tolerance. Trends Immunol. 33, 1-7 (2012).
36. Feuerer M, et al. Lean, but not obese, fat is enriched for a unique population of regula-Tory T cells that affect metabolic parameters. Nat. Med. 15, 930-939 (2009).
37. Arpaia N, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 504, 451-455 (2013).
38. Smith P.M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 341, 569-573 (2013).
39. Furusawa Y, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 504, 446-450 (2013).
40. Yang K, Neale G, Green D.R, He W, & Chi H. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat. Immunol. 12, 888-897 (2011).
41. Macintyre A.N, et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20, 61-72 (2014).
42. Cobbold S.P, et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. USA. 106, 12055-12060 (2009).
43. Finlay D.K, et al. Phosphoinositide-dependent kinase 1 controls migration and malig-nant transformation but not cell growth and proliferation in PTEN-null lymphocytes. J. Exp. Med. 206, 2441-2454 (2009).
44. Newton R.H, et al. Suppression of T-cell lymphomagenesis in mice requires PTEN phosphatase activity. Blood. 125, 852-855 (2015).
45. Huynh A, et al. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16, 188-196 (2015).
46. Delgoffe G.M, et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature. 501, 252-256 (2013).
47. Sharma M.D, et al. The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment. Sci Adv. 1, e1500845 (2015).
48. Patsoukis N, et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun. 6, 6692 (2015).
49. Haxhinasto S, Mathis D, & Benoist C. The AKT-mTOR axis regulates de novo dif-ferentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565-574 (2008).
50. Kerdiles Y.M, et al. Foxo transcription factors control regulatory T cell development and function. Immunity. 33, 890-904 (2010).
51. Ouyang W, et al. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11, 618-627 (2010).
52. Ouyang W, et al. Novel Foxo1-dependent transcriptional programs control Treg cell function. Nature. 491, 554-559 (2012).
53. Rao R.R, Li Q, Gubbels Bupp M.R, & Shrikant P.A. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8+ T cell dif-ferentiation. Immunity. 36, 374-387 (2012).
54. Tejera M.M, Kim E.H, Sullivan J.A, Plisch E.H, & Suresh M. FoxO1 controls effector-To-memory transition and maintenance of functional CD8 T cell memory. J. Immunol. 191, 187-199 (2013).
55. Shackelford D.B, & Shaw R.J. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer. 9, 563-575 (2009).
56. Blagih J, et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity. 42, 41-54 (2015).
57. Michalek R.D, et al. Estrogen-related receptor-A is a metabolic regulator of effector T-cell activation and differentiation. Proc. Natl. Acad. Sci. USA. 108, 18348-18353 (2011).
58. Wei J, et al. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat. Immunol. 17, 277-285 (2016).
59. Feng Y, et al. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell. 158, 749-763 (2014).
60. De Rosa V, et al. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat. Immunol. 16, 1174-1184 (2015).
61. Dang E.V, et al. Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell. 146, 772-784 (2011).
62. Clambey E.T, et al. Hypoxia-inducible factor-1 a-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc. Natl. Acad. Sci. USA. 109, E2784-E2793 (2012).
63. DuPage M, et al. The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation. Immunity. 42, 227-238 (2015).
64. Zhao E, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat. Immunol. 17, 95-103 (2016).
65. Li X, Liang Y, LeBlanc M, Benner C, & Zheng Y. Function of a Foxp3 cis-element in protecting regulatory T cell identity. Cell. 158, 734-748 (2014).
66. Sena L.A, et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity. 38, 225-236 (2013).
67. van Loosdregt J, et al. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood. 115, 965-974 (2010).
68. van Loosdregt J, et al. Rapid temporal control of Foxp3 protein degradation by sir-Tuin-1. PLoS One. 6, e19047 (2011).
69. Wellen K.E, et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 324, 1076-1080 (2009).
70. Gavin M.A, et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 445, 771-775 (2007).
71. Hubert S, et al. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J. Exp. Med. 207, 2561-2568 (2010).
72. Luo C.T, Liao W, Dadi S, Toure A, & Li M.O. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 529, 532-536 (2016).
73. Sukumar M, et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 123, 4479-4488 (2013).
74. Kawalekar O.U, et al. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity. 44, 380-390 (2016).
75. Deaglio S, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regu-latory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265 (2007).
76. Borsellino G, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 110, 1225-1232 (2007).
77. Leone R.D, Lo Y.C, & Powell J.D. A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy. Comput. Struct. Biotechnol. J. 13, 265-272 (2015).
78. Shrestha S, et al. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat. Immunol. 16, 178-187 (2015).
79. Bian L, et al. Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res. Ther. 11, R132 (2009).
80. Thebault P, et al. Role of IFNg in allograft tolerance mediated by CD4+CD25+ regula-Tory T cells by induction of IDO in endothelial cells. Am. J. Transplant. 7, 2472-2482 (2007).
81. Sundrud M.S, et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science. 324, 1334-1338 (2009).
82. Beier U.H, et al. Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival. Mol. Cell. Biol. 31, 1022-1029 (2011).
83. Tao R, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299-1307 (2007).
84. Price N.L, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 15, 675-690 (2012).
85. Gatza E, et al. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci. Transl. Med. 3, 67ra8 (2011).
86. Byersdorfer C.A, et al. Effector T cells require fatty acid metabolism during murine graft-versus-host disease. Blood. 122, 3230-3237 (2013).